Abstract:Background: Excessive lead exposure is associated with adverse health effects. However, there is a lack of systematic investigation using large populations to ascertain acceptable exposure limits. Objectives: Our study was aimed to identify human exposure-response relationships between lead exposure and health-related outcomes, and to determine a benchmark dose (BMD). Methods: A total of 1896 participants from a lead-acid battery plant were recruited. Blood lead levels (BLLs) were detected for all participants. Hematological parameters (n = 1896), micronuclei (MN) frequencies (n = 934), and relative telomere length (rTL) (n = 757) were also determined. Multivariate linear/Poisson regression analyses were performed to examine associations between BLLs and these health outcomes. Restricted cubic splines were used to identify dose-response relationships. Three BMD approaches were used to calculate BMD and its 95% lower confidence limit (BMDL). Results: Among all participants, BLLs show a right-skewed distribution (median, 185.40 mu g/L; 25th - 75th percentile, 104.63-271.70 mu g/L). There existed significant differences for red blood cell (RBC), hemoglobin (Hb), MN and rTL among different BLL dose groups. After adjusting for possible confounders, all indicators were significantly associated with BLLs. Restricted cubic splines show that there were linear dose-response relationships for RBC and Hb with BLLs, while non-linear for MN and rTL. Results from the three BMD approaches indicate that the dichotomous models were better than continuous models to calculate BMD and BMDL of BLLs. The conservative BMDL obtained from RBC data was 135 for total, 104 for male and 175 mu g/L for female. The corresponding BMDL obtained from Hb data was 105 for total, 116 for male and 70 mu g/L for female. As for MN data, the BMDL estimate was 66 for total, 69 for male and 64 mu g/L for female. Finally, the BMDL from rTL data was 35 for total, 32 for male and 43 mu g/L for female. Conclusions: Our data show significant dose-response relationships between lead exposure and expressions of hematological toxicity and genotoxicity. The new BMDLs of 135 and 105 mu g/L based on RBC and Hb, and even more strict level of 66 and 35 mu g/L based on MN and rTL are lower than current exposure limits in China. Therefore, the four values can be considered as novel exposure limits. In addition, sex effect should be taken into account when setting occupational health standard. Considering that different biomarkers have different sensitivities, better understanding their relationships will certainly improve the current emphasis on precision health risk assessment.

[Application of Benchmark Dose on Occupational Epidemiology Research in Lead Exposure].

Application of Benchmark Dose for Occupational Epidemiology in Lead Exposure

Benchmark Dose Approach for Renal Dysfunction in Workers Exposed to Lead

[Application of Benchmark Dose on Renal Injury in People Chronically Exposed to Lead].

Application of the Benchmark Dose (BMD) Method to Identify Thresholds of Cadmium-Induced Renal Effects in Non-Polluted Areas in China.

Estimation of benchmark dose for bone damage and renal dysfunction in a Chinese male population occupationally exposed to lead.

Risk assessment of renal dysfunction caused by occupational lead exposure

Application of Benchmark Dose (BMD) in Estimating Biological Exposure Limit (BEL) to Cadmium.

Development of a Benchmark Dose for Lead-Exposure Based on Its Induction of Micronuclei, Telomere Length Changes and Hematological Toxicity.

Benchmark Dose Estimation for Cadmium-Induced Renal Tubular Damage among Environmental Cadmium-Exposed Women Aged 35-54 Years in Two Counties of China

[Application of Benchmark Dose (BMD) in a Bone-Effect Study on a General Population Environmentally Exposed to Cadmium].

Environmental epidemiological study and estimation of benchmark dose for renal dysfunction in a cadmium-polluted area in China

The Reference Dose for Subchronic Exposure of Pigs to Cadmium Leading to Early Renal Damage by Benchmark Dose Method.

Benchmark dose estimation of urinary and blood cadmium as biomarkers of renal dysfunction among 40‐75‐year‐old non‐smoking women in rural areas of southwest China

Benchmark Dose Estimation for Cadmium-Induced Renal Effects Based on a Large Sample Population from Five Chinese Provinces

Comparison of sensitivity between blood parameters and a genotoxic biomarker at low blood Pb levels: A population-based study

Benchmark Dose Approach for Low-Level Lead Induced Haematogenesis Inhibition and Associations of Childhood Intelligences with ALAD Activity and ALA Levels.

Metal Biomonitoring and Comparative Assessment in Urine of Workers in Lead-Zinc and Steel-Iron Mining and Smelting

Application Of Bmd Approach To Identify Thresholds Of Cadmium-Induced Renal Effect Among 35 To 55 Year-Old Women In Two Cadmium Polluted Counties In China

Benchmark dose modeling for epidemiological dose-response assessment using prospective cohort studies

[Benchmark dose estimation of polycyclic aromatic hydrocarbons exposure base on Bayesian kernel machine regression]